Association of Migraine and Vasomotor Symptoms
- PMID: 37137642
- PMCID: PMC10157023
- DOI: 10.1016/j.mayocp.2023.01.010
Association of Migraine and Vasomotor Symptoms
Abstract
Objective: To further examine a potential link between migraine and vasomotor symptoms as well as hypertension as a cardiovascular disease risk factor, potentially explaining the association in midlife women.
Patients and methods: We conducted a cross-sectional analysis from the Data Registry on Experiences of Aging, Menopause, and Sexuality using questionnaire data from women aged 45 to 60 years seen in women's clinics at a tertiary care center from May 15, 2015, through January 31, 2022. A history of migraine was self-reported; menopause symptoms were assessed with the Menopause Rating Scale. Associations between migraine and vasomotor symptoms were evaluated utilizing multivariable logistic regression models adjusting for multiple factors.
Results: Of 5708 women included in the analysis, 1354 (23.7%) reported a migraine history. The total cohort had a mean age of 52.8 years, most (5184 [90.8%]) were White, and 3348 (58.7%) were postmenopausal. In adjusted analysis, women with migraine were significantly more likely to have severe/very severe hot flashes vs no hot flashes compared with women without migraine (odds ratio, 1.34; 95% CI, 1.08 to 1.66; P=.007). Migraine was associated with a diagnosis of hypertension in adjusted analysis (odds ratio, 1.31; 95% CI, 1.11 to 1.55; P=.002).
Conclusion: This large cross-sectional study confirms an association between migraine and vasomotor symptoms. Migraine also was associated with hypertension, potentially providing a link with cardiovascular disease risk. Given the high prevalence of migraine in women, this association may help identify those at risk for more severe menopause symptoms.
Copyright © 2023 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest:
SSF-none
TS-none
JT-none
JMK- past consulting for Proctor and Gamble and Triangle Insights group
CLS - none
KM-none
FE-none
EK-consultant for Mithra Pharmaceuticals, Scynexis, and Astellas Pharma and for Womaness
Figures
Similar articles
-
Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies.Am J Obstet Gynecol. 2020 Dec;223(6):898.e1-898.e16. doi: 10.1016/j.ajog.2020.06.039. Epub 2020 Jun 23. Am J Obstet Gynecol. 2020. PMID: 32585222 Free PMC article.
-
Vasomotor symptoms in women over 60: results from the Data Registry on Experiences of Aging, Menopause, and Sexuality (DREAMS).Menopause. 2018 Oct;25(10):1105-1109. doi: 10.1097/GME.0000000000001126. Menopause. 2018. PMID: 29738420
-
Prevalence and impact of vasomotor symptoms associated with menopause among women in Brazil: Subgroup analysis from an international cross-sectional survey.Maturitas. 2024 Nov;189:108114. doi: 10.1016/j.maturitas.2024.108114. Epub 2024 Sep 6. Maturitas. 2024. PMID: 39317029
-
Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis.PLoS One. 2016 Jun 17;11(6):e0157417. doi: 10.1371/journal.pone.0157417. eCollection 2016. PLoS One. 2016. PMID: 27315068 Free PMC article. Review.
-
Vasomotor symptoms and cardiovascular health: findings from the SWAN and the MsHeart/MsBrain studies.Climacteric. 2024 Feb;27(1):75-80. doi: 10.1080/13697137.2023.2196001. Epub 2023 Aug 14. Climacteric. 2024. PMID: 37577812 Review.
Cited by
-
Migraines, vasomotor symptoms, and cardiovascular disease in the Coronary Artery Risk Development in Young Adults study.Menopause. 2024 Mar 1;31(3):202-208. doi: 10.1097/GME.0000000000002311. Epub 2024 Feb 13. Menopause. 2024. PMID: 38350045
-
Arterial hypertension in the chronic evolution of migraine: bystander or risk factor? An overview.J Headache Pain. 2024 Feb 5;25(1):13. doi: 10.1186/s10194-024-01720-7. J Headache Pain. 2024. PMID: 38311745 Free PMC article. Review.
-
Prospective early adulthood risk factors for vasomotor symptoms in the Coronary Artery Risk Development in Young Adults study.Menopause. 2024 Feb 1;31(2):108-115. doi: 10.1097/GME.0000000000002306. Menopause. 2024. PMID: 38270902
References
-
- Burch R, Rizzoli P, Loder E. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies. Headache. 2018;58(4):496–505. - PubMed
-
- Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009;29(3):286–292. - PubMed
-
- MacDonald CJ, El Fatouhi D, Madika AL, et al. Association of Migraine With Incident Hypertension After Menopause: A Longitudinal Cohort Study. Neurology. 2021;97(1):e34–e41. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
